Reversing FXa inhibitor activity in patients with acute major bleeding
Monday, May 22nd, 2023 | 11:00 AM - 12:00 PM CT
Every day, patients are hospitalized with a factor Xa (FXa) inhibitor-related acute major bleed. For those patients, every moment matters. Uncover the latest information on managing patients with FXa inhibitor-related acute major bleeding in this live discussion.
- The burden of life-threatening bleeds related to FXa Inhibitors
- The rationale behind the reversal of anti-FXa activity
- Clinical trials evaluating the efficacy and safety of FXa inhibitor reversal
- Real world studies evaluating FXa inhibitor reversals